Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PACS Group, Inc.PACS · Entity 2590 | Director · Co-Founder, CEO & Chairman · 10% owner | October 06, 2026 | October 07, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PACS Group, Inc.
Report date October 06, 2026 · Filed October 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 54,435,249 |
Ending reported balance
After 2026-10-07 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2026-10-06 · Sale · Disposed 28,753 · Balance 54,443,188 F1: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. F2: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $42.53 to $43.51 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 2 · 2026-10-06 · Sale · Disposed 7,222 · Balance 54,435,966 F1: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. F3: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.53 to $43.79 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 3 · 2026-10-07 · Sale · Disposed 717 · Balance 54,435,249 F1: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026.
F2: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $42.53 to $43.51 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.53 to $43.79 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 07, 2026 Filed Oct 7, 2026 22:05 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 717 | $42.48 | $30,458.16 |
DisclosureSEC source: 0002014386-26-000018 · wk-form4_1791410703.xml · nonDerivative · entry 3 Murray Jason Hulse · CIK 0002014386 · Director · Co-Founder, CEO & Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,435,249 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. Read SEC document |
| October 06, 2026 Filed Oct 7, 2026 22:05 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 7,222 | $43.64 | $315,146.41 |
DisclosureSEC source: 0002014386-26-000018 · wk-form4_1791410703.xml · nonDerivative · entry 2 Murray Jason Hulse · CIK 0002014386 · Director · Co-Founder, CEO & Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,435,966 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. F3 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.53 to $43.79 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 06, 2026 Filed Oct 7, 2026 22:05 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 28,753 | $42.96 | $1,235,096.62 |
DisclosureSEC source: 0002014386-26-000018 · wk-form4_1791410703.xml · nonDerivative · entry 1 Murray Jason Hulse · CIK 0002014386 · Director · Co-Founder, CEO & Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,443,188 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. F2 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $42.53 to $43.51 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 05, 2026 Filed Oct 5, 2026 22:17 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 24,224 | $42.66 | $1,033,277.14 |
DisclosureSEC source: 0002014386-26-000016 · wk-form4_1791238657.xml · nonDerivative · entry 4 Murray Jason Hulse · CIK 0002014386 · Director · Co-Founder, CEO & Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,471,941 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. F5 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $42.39 to $43.125 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 02, 2026 Filed Oct 5, 2026 22:17 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 23,456 | $42.59 | $999,063.75 |
DisclosureSEC source: 0002014386-26-000016 · wk-form4_1791238657.xml · nonDerivative · entry 3 Murray Jason Hulse · CIK 0002014386 · Director · Co-Founder, CEO & Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,496,165 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. F4 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $42.10 to $42.94 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 02, 2026 Filed Oct 5, 2026 22:17 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 2,596 | $41.79 | $108,487.36 |
DisclosureSEC source: 0002014386-26-000016 · wk-form4_1791238657.xml · nonDerivative · entry 2 Murray Jason Hulse · CIK 0002014386 · Director · Co-Founder, CEO & Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,519,621 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. F3 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $41.10 to $42.07 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 01, 2026 Filed Oct 5, 2026 22:17 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 33,032 | $41.13 | $1,358,457.52 |
DisclosureSEC source: 0002014386-26-000016 · wk-form4_1791238657.xml · nonDerivative · entry 1 Murray Jason Hulse · CIK 0002014386 · Director · Co-Founder, CEO & Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,522,217 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. F2 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $40.635 to $41.575 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 14, 2026 Filed Sep 14, 2026 22:38 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 317 | $45.03 | $14,274.80 |
DisclosureSEC source: 0002014386-26-000014 · wk-form4_1789425494.xml · nonDerivative · entry 3 Murray Jason Hulse · CIK 0002014386 · Director · Co-Founder, CEO & Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,555,249 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. F4 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.12 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 11, 2026 Filed Sep 14, 2026 22:38 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 10,529 | $45.23 | $476,189.82 |
DisclosureSEC source: 0002014386-26-000014 · wk-form4_1789425494.xml · nonDerivative · entry 2 Murray Jason Hulse · CIK 0002014386 · Director · Co-Founder, CEO & Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,555,566 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. F3 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.76 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 10, 2026 Filed Sep 14, 2026 22:38 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 8,771 | $45.16 | $396,105.38 |
DisclosureSEC source: 0002014386-26-000014 · wk-form4_1789425494.xml · nonDerivative · entry 1 Murray Jason Hulse · CIK 0002014386 · Director · Co-Founder, CEO & Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,566,095 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. F2 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.4775 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 09, 2026 Filed Sep 9, 2026 21:38 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 4,758 | $43.33 | $206,147.01 |
DisclosureSEC source: 0002014386-26-000012 · wk-form4_1788989878.xml · nonDerivative · entry 5 Murray Jason Hulse · CIK 0002014386 · Director · Co-Founder, CEO & Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,574,866 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. F6 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $42.89 to $43.66 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 08, 2026 Filed Sep 9, 2026 21:38 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 21,001 | $43.59 | $915,530.19 |
DisclosureSEC source: 0002014386-26-000012 · wk-form4_1788989878.xml · nonDerivative · entry 4 Murray Jason Hulse · CIK 0002014386 · Director · Co-Founder, CEO & Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,579,624 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. F5 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.29 to $43.90 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 08, 2026 Filed Sep 9, 2026 21:38 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 3,056 | $42.80 | $130,797.11 |
DisclosureSEC source: 0002014386-26-000012 · wk-form4_1788989878.xml · nonDerivative · entry 3 Murray Jason Hulse · CIK 0002014386 · Director · Co-Founder, CEO & Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,600,625 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. F4 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $42.25 to $43.22 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 04, 2026 Filed Sep 9, 2026 21:38 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 243 | $43.14 | $10,484.11 |
DisclosureSEC source: 0002014386-26-000012 · wk-form4_1788989878.xml · nonDerivative · entry 2 Murray Jason Hulse · CIK 0002014386 · Director · Co-Founder, CEO & Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,603,681 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. F3 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.14 to $43.16 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 04, 2026 Filed Sep 9, 2026 21:38 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 22,829 | $42.68 | $974,414.77 |
DisclosureSEC source: 0002014386-26-000012 · wk-form4_1788989878.xml · nonDerivative · entry 1 Murray Jason Hulse · CIK 0002014386 · Director · Co-Founder, CEO & Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,603,924 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. F2 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $42.11 to $43.10 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 03, 2026 Filed Sep 4, 2026 00:21 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 858 | $43.11 | $36,987.35 |
DisclosureSEC source: 0002014386-26-000010 · wk-form4_1788481278.xml · nonDerivative · entry 6 Murray Jason Hulse · CIK 0002014386 · Director · Co-Founder, CEO & Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,626,753 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. F7 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.07 to $43.24 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 03, 2026 Filed Sep 4, 2026 00:21 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 19,315 | $42.53 | $821,495.92 |
DisclosureSEC source: 0002014386-26-000010 · wk-form4_1788481278.xml · nonDerivative · entry 5 Murray Jason Hulse · CIK 0002014386 · Director · Co-Founder, CEO & Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,627,611 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. F6 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $42.065 to $43.06 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 02, 2026 Filed Sep 4, 2026 00:21 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 6,348 | $43.36 | $275,274.04 |
DisclosureSEC source: 0002014386-26-000010 · wk-form4_1788481278.xml · nonDerivative · entry 4 Murray Jason Hulse · CIK 0002014386 · Director · Co-Founder, CEO & Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,646,926 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. F5 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.20 to $43.78 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 02, 2026 Filed Sep 4, 2026 00:21 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 17,435 | $42.78 | $745,947.76 |
DisclosureSEC source: 0002014386-26-000010 · wk-form4_1788481278.xml · nonDerivative · entry 3 Murray Jason Hulse · CIK 0002014386 · Director · Co-Founder, CEO & Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,653,274 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. F4 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $42.20 to $43.19 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 01, 2026 Filed Sep 4, 2026 00:21 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 1,368 | $43.05 | $58,890.21 |
DisclosureSEC source: 0002014386-26-000010 · wk-form4_1788481278.xml · nonDerivative · entry 2 Murray Jason Hulse · CIK 0002014386 · Director · Co-Founder, CEO & Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,670,709 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. F3 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $42.99 to $43.19 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 01, 2026 Filed Sep 4, 2026 00:21 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 22,789 | $42.35 | $965,157.45 |
DisclosureSEC source: 0002014386-26-000010 · wk-form4_1788481278.xml · nonDerivative · entry 1 Murray Jason Hulse · CIK 0002014386 · Director · Co-Founder, CEO & Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,672,077 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. F2 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $41.92 to $42.90 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 21, 2026 Filed Aug 24, 2026 21:56 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 27,590 | $44.25 | $1,220,771.97 |
DisclosureSEC source: 0002014386-26-000008 · wk-form4_1787608584.xml · nonDerivative · entry 4 Murray Jason Hulse · CIK 0002014386 · Director · Co-Founder, CEO & Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,694,866 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. F5 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $44.05 to $44.52 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 21, 2026 Filed Aug 24, 2026 21:56 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 31,654 | $43.61 | $1,380,313.82 |
DisclosureSEC source: 0002014386-26-000008 · wk-form4_1787608584.xml · nonDerivative · entry 3 Murray Jason Hulse · CIK 0002014386 · Director · Co-Founder, CEO & Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,722,456 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. F4 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.05 to $44.045 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 20, 2026 Filed Aug 24, 2026 21:56 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 13,879 | $44.76 | $621,258.74 |
DisclosureSEC source: 0002014386-26-000008 · wk-form4_1787608584.xml · nonDerivative · entry 2 Murray Jason Hulse · CIK 0002014386 · Director · Co-Founder, CEO & Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,754,110 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. F3 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $44.31 to $45.165 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 20, 2026 Filed Aug 24, 2026 21:56 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 77,427 | $43.77 | $3,389,088.19 |
DisclosureSEC source: 0002014386-26-000008 · wk-form4_1787608584.xml · nonDerivative · entry 1 Murray Jason Hulse · CIK 0002014386 · Director · Co-Founder, CEO & Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,767,989 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. F2 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.30 to $44.29 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 19, 2026 Filed Aug 20, 2026 00:32 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 67 | $44.85 | $3,004.76 |
DisclosureSEC source: 0002014386-26-000006 · wk-form4_1787185923.xml · nonDerivative · entry 5 Murray Jason Hulse · CIK 0002014386 · Director · Co-Founder, CEO & Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,845,416 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. F6 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $44.845 to $44.86 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 19, 2026 Filed Aug 20, 2026 00:32 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 84,650 | $44.26 | $3,746,989.93 |
DisclosureSEC source: 0002014386-26-000006 · wk-form4_1787185923.xml · nonDerivative · entry 4 Murray Jason Hulse · CIK 0002014386 · Director · Co-Founder, CEO & Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,845,483 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. F5 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.84 to $44.80 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 18, 2026 Filed Aug 20, 2026 00:32 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 66,797 | $44.18 | $2,951,138.22 |
DisclosureSEC source: 0002014386-26-000006 · wk-form4_1787185923.xml · nonDerivative · entry 3 Murray Jason Hulse · CIK 0002014386 · Director · Co-Founder, CEO & Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,930,133 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. F4 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.81 to $44.67 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 17, 2026 Filed Aug 20, 2026 00:32 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 74,844 | $44.27 | $3,313,373.82 |
DisclosureSEC source: 0002014386-26-000006 · wk-form4_1787185923.xml · nonDerivative · entry 2 Murray Jason Hulse · CIK 0002014386 · Director · Co-Founder, CEO & Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,996,930 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. F3 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.81 to $44.51 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 17, 2026 Filed Aug 20, 2026 00:32 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 9,758 | $43.34 | $422,927.33 |
DisclosureSEC source: 0002014386-26-000006 · wk-form4_1787185923.xml · nonDerivative · entry 1 Murray Jason Hulse · CIK 0002014386 · Director · Co-Founder, CEO & Chairman · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 55,071,774 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026. F2 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $42.805 to $43.8025 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 24, 2026 Filed Mar 26, 2026 22:10 UTC | PACS Group, Inc. PACS · Entity 2590 | GrantCommon Stock | 234,397 | $0.00 | $0.00 |
DisclosureSEC source: 0002014386-26-000004 · wk-form4_1774563020.xml · nonDerivative · entry 1 Murray Jason Hulse · CIK 0002014386 · Director · Co-Founder, CEO & Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,081,532 F1 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs will vest in substantially equal annual installments on the first, second, and third anniversaries of March 24, 2026, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| January 15, 2026 Filed Jan 20, 2026 21:56 UTC | PACS Group, Inc. PACS · Entity 2590 | Tax withholdingCommon Stock | 20,082 | $39.49 | $793,038.18 |
DisclosureSEC source: 0002014386-26-000002 · wk-form4_1768946164.xml · nonDerivative · entry 1 Murray Jason Hulse · CIK 0002014386 · Director · Co-Founder, CEO & Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,847,135 F1 · kind: Payment of tax liability through the withholding of securities upon the vesting of previously granted and reported restricted stock units. Read SEC document |
| December 17, 2025 Filed Dec 19, 2025 21:28 UTC | PACS Group, Inc. PACS · Entity 2590 | GrantCommon Stock | 41,018 | $0.00 | $0.00 |
DisclosureSEC source: 0002014386-25-000005 · wk-form4_1766179720.xml · nonDerivative · entry 2 Murray Jason Hulse · CIK 0002014386 · Director · Co-Founder, CEO & Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,867,217 F2 · shares: Represents RSUs for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs will vest in substantially equal annual installments on the first, second, and third anniversaries of November 25, 2025, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| December 17, 2025 Filed Dec 19, 2025 21:28 UTC | PACS Group, Inc. PACS · Entity 2590 | GrantCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0002014386-25-000005 · wk-form4_1766179720.xml · nonDerivative · entry 1 Murray Jason Hulse · CIK 0002014386 · Director · Co-Founder, CEO & Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,826,199 F1 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs will vest in substantially equal annual installments on the first, second, and third anniversaries of January 15, 2025, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| September 09, 2024 Filed Sep 10, 2024 20:01 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 8,128,352 | $36.25 | $294,652,760.00 |
DisclosureSEC source: 0001628280-24-040014 · wk-form4_1725998500.xml · nonDerivative · entry 1 Murray Jason Hulse · CIK 0002014386 · Director · Co-Founder, CEO & Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,126,199 Read SEC document |
| April 15, 2024 Filed Apr 15, 2024 20:02 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 1,607,142 | $21.00 | $33,749,982.00 |
DisclosureSEC source: 0001628280-24-016205 · wk-form4_1713211365.xml · nonDerivative · entry 1 Murray Jason Hulse · CIK 0002014386 · Director · Co-Founder, CEO & Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,754,551 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.